Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.19 USD | +1.64% | -3.58% | +44.63% |
05-09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.63% | 66.6M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.67% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- Lantern Pharma Doses First Patient in Phase 1 Trial of Advanced Solid Tumor Drug Candidate